
Stephen Levin | Expert MedTech Insight & Analysis
@StephenLevinMTS
Followers
236
Following
6K
Media
5
Statuses
2K
Co-Editor-in-Chief/Managing Partner for @MedTechStrat & @Market_Pathways. We offer #medtech executives with actionable intelligence & unparalleled perspective.
New Jersey, USA
Joined June 2018
RT @Market_Pathways: Medtech has been accelerating innovation in product development with a record 124 new #devices approved by the FDA in….
0
2
0
RT @MedTechStrat: How are VCs adapting to an evolving #medtech market? At #InnovationDublin25, leading investors discuss strategies, challe….
0
2
0
RT @Market_Pathways: Federal agencies including #FDA have retreated from various forms of public and stakeholder engagement during the open….
0
2
0
RT @Market_Pathways: NEW EP. of @Market_Pathways Podcast: Following a robust 2024, the medical device sector continues to thrive in 2025 an….
0
4
0
RT @Market_Pathways: Be the expert in the room. Stay ahead of the curve in #medtech regulatory, reimbursement, and policy with Pathways' Do….
0
4
0
RT @MedTechStrat: Ortho, spine, and #medtech are thriving, but elective procedures face economic and political uncertainties. @MedTechStrat….
0
3
0
RT @MedTechStrat: #Robotics pioneer @IntuitiveSurg continues to be the dominant player with greater than 80% market share, nearly 10,000 da….
0
4
0
RT @Market_Pathways: Explore the barriers and opportunities learn directly from key decision-makers and read stories of companies that are….
0
4
0
RT @MedTechStrat: The future of medtech is taking shape at @MedTechStrat #InnovationDB25. From April 29–May 1, join 300+ #medtech leaders,….
0
6
0
RT @RILifeSciHub: ICYMI: Life Science Hub CEO Dr. Mark A. Turco discussed his career journey and vision for RI's life sciences sector with….
0
4
0
RT @MedTechStrat: Join @GildeHealthcare's Janke Dittmer, @SofinnovaVC's Aantoine Papiernik, and @EndeavourVision's Alexander Schmitz at #In….
0
2
0
RT @Market_Pathways: Each month in Global Spotlight we provide #marketaccess facts from the country spotlighted on the cover of Market Path….
0
3
0
RT @Market_Pathways: Medtech CEOs, investors, and #reimbursement authorities share their views on the current state of #medtech coding, cov….
0
3
0
RT @MedTechStrat: Everyone can appreciate a two for one deal. And MyStrategist is your one digital home for two of the #medtech industry's….
0
2
0
RT @Market_Pathways: Orphan devices—specialized #medicaldevices for rare conditions—face #regulatory hurdles under the EU MDR. While new….
0
3
0
RT @Market_Pathways: Europe just enacted new requirements for device manufacturers to report anticipated product supply disruptions, and @U….
0
2
0
RT @Market_Pathways: The biggest issue for #medtech execs isn’t regulatory—it’s #reimbursement. With CMS transparency concerns and complex….
0
2
0
RT @Market_Pathways: Will the U.S. follow Europe’s lead on device shortage reporting This compares the EU’s new Article 10a, which mandates….
0
2
0
RT @MedTechStrat: Everyone can appreciate a two for one deal. And MyStrategist is your one digital home for two of the #MedTech industry'….
0
2
0